Disruptions in GRIN3A expression or function may lead to aberrant glutamate signaling, potentially contributing to the pathophysiology of various neurological disorders, including schizophrenia, autism spectrum disorder, and intellectual disability [20, 21, 22, 23]. This evidence concerns the gene GRIN3A and nervous system disorder.